Boron trifluoride etherate → Methyl 7-methoxy-2,3-dihydrobenzo[f][1,4]thiazepine-4(5H)-carboxylate
Reaktionsgleichung
O[CH2:2][N:3]([CH2:8][CH2:9][S:10][C:11]1[CH:16]=[CH:15][C:14]([O:17][CH3:18])=[CH:13][CH:12]=1)[C:4](=[O:7])[O:5][CH3:6].B(F)(F)F.O(CC)CC>C(Cl)Cl>[CH3:18][O:17][C:14]1[CH:13]=[CH:12][C:11]2[S:10][CH2:9][CH2:8][N:3]([C:4]([O:5][CH3:6])=[O:7])[CH2:2][C:16]=2[CH:15]=1Komponenten
4
Versuchsvorschrift
A solution of compound 9 (20.0 mg) in 10 mL CH2Cl2 was treated with 1.1 eq. of BF3—OEt2 under Ar. The mixture was stirred overnight and washed with 1N HCl and sat. NaHCO3 Removal of the solvent gave the crude product and TLC analysis showed one major spot. The crude product was further purified on SiO2 column to provide the title compound (16 mg). The structure was confirmed by NMR and TLC comparison with authentic sample prepared by the reaction of 7-MeO-2,3,4,5-tetrahydro-1,4-benzothiazepine with methyl chloroformate.
Aufarbeitung
- washwashed with 1N HCl and sat. NaHCO3 Removal of the solvent
- customgave the crude product and TLC analysis
- customThe crude product was further purified on SiO2 column
Quellen und Nachweise
- ORD-Eintrag
- ord-f87f46c5e6a243e0872f8935e4f03aef
- Quelldatensatz
- uspto-grants-2013_12
- Patentnummer
- US08618282B2
Notizen zur Reaktion
Wird geladen…